NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
115 hedge funds and large institutions have $705M invested in NxStage Medical Inc. in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 51 increasing their positions, 32 reducing their positions, and 13 closing their positions.
59% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 32
45% more call options, than puts
Call options by funds: $1.86M | Put options by funds: $1.29M
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
3% less funds holding
Funds holding: 118 → 115 (-3)
8% less capital invested
Capital invested by funds: $769M → $705M (-$63.7M)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$14.7M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$14.2M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$7.88M |
| 4 |
BA
Broadview Advisors
Milwaukee,
Wisconsin
|
+$5.43M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$4.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$32.2M |
| 2 |
PWPCM
Perella Weinberg Partners Capital Management
New York
|
-$6.34M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.32M |
| 4 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
-$4.16M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$3.8M |
NXTM Hedge Fund Activity: Q3 2013 in Review
115 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q3 2013, worth a combined $705M — down 8.3% from $769M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of NXTM and 11 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 51 added.
The largest buyer was Deerfield Management, adding an estimated $14.7M. The largest seller was Sectoral Asset Management, cutting an estimated $32.2M.
- 115 institutional investors held NxStage Medical Inc. (NXTM) as of Q3 2013, down from 118 in Q2 2013.
- Funds reported $705M of NxStage Medical Inc. stock for Q3 2013, down 8.3% quarter-over-quarter.
- 11 funds opened new NxStage Medical Inc. positions in Q3 2013 and 13 closed out, a net change of -2 holders.
- The largest NxStage Medical Inc. buyer in Q3 2013 was Deerfield Management, an estimated $14.7M added.
- The largest NxStage Medical Inc. seller in Q3 2013 was Sectoral Asset Management, an estimated $32.2M sold.
Based on aggregated 13F filings for Q3 2013.